Conclusion
MC twin pregnancies with sIUFD remain complex and high-risk. They should not be treated as low-risk singleton pregnancies. Women at risk of developing sepsis (prenatal therapy) should be closely monitored. It is not clear what gestation to deliver the surviving co-twin; this should be investigated with a randomised controlled trial but given the relative rarity of sIUFD this is unlikely to occur. Preterm birth was the commonest adverse outcome, and more research is required in this area. Awareness of the importance of CNS imaging, and follow-up, needs to be increased, and may be aided by better communication between specialities and hospitals.